Novel polymer-grafted starch microparticles for mucosal delivery of vaccines

Immunology

Volumn 88, Issue 1, 1996, Pages 162-168

  Heritage, P L ^a   Loomes, L M ^a   Jianxiong, J ^b   Brook, M A ^b   Underdown, B J ^a   Mcdermott, M R ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETICONE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICROPARTICLE; POLYMER; SILICONE; STARCH; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029922749     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-639.x     Document Type: Article

References (39)

1. FAZEKAS DE ST GROTH S. (1951) Studies in experimental immunology of influenza. IX. The mode of action of pathotopic adjuvants. Aust J Exp Biol Med Sci 29, 339.
2. KENRICK K.G. & COOPER G.N. (1978) Antibodies in the intestinal secretions of rats: primary and secondary responses to polymeric flagellin. Aust J Exp Biol Med Sci 56, 441.
3. MCDERMOTT M.R. & BIENENSTOCK J. (1979) Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol 122, 1892.
4. WEISZ-CARRINGTON P., ROUX M.E., MCWILLIAMS M., PHILLIPS-QUAGLIATA J.M. & LAMM M.E. (1979) Organ and isotype distribution of plasma cells producing specific antibody after oral immunization and evidence for a generalized secretory immune system. J Immunol 123, 1705.
5. DUDDING B.A., TOP F.H., SCOTT R.M., RUSSELL P.K. & BUESCHER E.L. (1972) An analysis of hospitalization for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. Am J Epidemiol 95, 140.
6. MELNICK J.L. (1978) Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull WHO 56, 21.
7. ELSON C.O. & DERTZBAUGH M.T. (1994) Mucosal adjuvants. In: Handbook of Mucosal Immunology (eds P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee & J. Bienenstock), p. 391. Academic Press NY.
8. GUZMAN C.A., MOLINARI G., FOUNTAIN M.W., ROHDE M., TIMMIS K.N. & WALKER M.J. (1993) Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid. Infect Immun 61, 573.
9. JACKSON S., MESTECKY J., CHILDERS N.K. & MICHALEK S.M. (1990) Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect Immun 58, 1932.
10. MICHALEK S.M., CHILDERS N.K., KATZ J. et al. (1989) Liposomes as oral adjuvants. Curr Top Microbiol Immunol 146, 51.
11. MOWAT A.MCI., DONACHIE A.M., REID G. & JARRETT O. (1991) Immune-stimulating complexes containing quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and immunogenic by the oral route. Immunology 72, 317.
12. MOWAT A.MCI., MALOY K.J. & DONACHIE A.M. (1993) Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunology 80, 527.
13. GOULD-FOGERITE S. & MANNINO R.J. (1993) Targeted fusogenic proteoliposomes: functional reconstitution of membrane proteins through protein-cochleate intermediates. In: Liposome Technology (ed. G. Gregoriadis), Vol. III, 2nd edn, p. 261. CRC Press, London.
14. COWSAR D.R., TICE T.R., GILLEY R.M. & ENGLISH J.P. (1985) Poly(lactide-co-glycolide) microspheres for controlled release of steroids. Meth Enzymol 112, 101.
15. CHALLACOMBE S.J., RAHMAN D., JEFFERY H., DAVIS S.S. & O'HAGAN D.T. (1992) Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76, 164.
16. ELDRIDGE J.H., GILLEY R.M., STAAS J.K., MOLDOVEANU Z., MEULBROEK J.A. & TICE T.R. (1989) Biodegradable microspheres: vaccine delivery system for oral immunization. Curr Top Microbiol Immunol 146, 59.
17. ELDRIDGE J.H., HAMMOND C.J., MEULBROEK J.A., STAAS J.K., GILLEY R.M. & TICE T.R. (1990) Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Rel 11, 205.
18. O'HAGAN D.T., MCGHEE J.P., HOLMGREN J. et al. (1993) Biodegradable microparticles for oral immunization. Vaccine 11, 149.
19. ALONSO M.J., GUPTA R.K., MIN C., SIBER G.R. & LANGER R. (1994) Biodegradable microspheres as a controlled-release tetanus toxoid delivery system. Vaccine 12, 299.
20. SANTIAGO N., MILSTEIN S., RIVERA T. et al. (1993) Oral immunization of rats with protcinoid microspheres encapsulating influenza virus antigens. Pharmaceut Res 10, 1243.
21. PAYNE L.G., JENKINS S.A., ANDRIANOV A. & ROBERTS B.E. (1995) in press.
22. MORA M. & PATO J. (1993) Preparation of egg albumin microparticles for oral application. J Control Rel 25, 107.
23. YAPEL A.F. (1985) Albumin microspheres: heat and chemical stabilization. Meth Enzymol 112, 3.
24. ARTURSSON P., EDMAN P., LAAKSO T. & SJOHOLM I. (1984) Characterization of polyacryl starch microparticles as carriers for proteins and drugs. J Pharmaceut Sci 73, 1507.
25. MARX P.A., COMPANS R.W., AGEGNEHU G. et al. (1993) Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260, 1323.
26. MOLDOVEANU Z., NOVAK M., HUANG, W.-Q. et al. (1993) Oral immunization with influenza in biodegradable microparticles. J Inject Dis 167, 84.
27. SMITH A.L. (1991) The Analytical Chemistry of Silicones. Wiley NY.
28. MARKWELL M.A. & FOX C.F. (1978) Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril. Biochemistry 17, 4807.
29. JANI P.U., MCCARTHY D.E. & FLORENCE A.T. (1992) Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single dose. Int J Pharaceut 86, 239.
30. JOEL D.D., LAISSUE J.A. & E FEVRE M.E. (1978) Distribution and fate of ingested carbon particles in mice. J Reticulo Soc 24, 477.
31. LEFEVRE M.E., JOEL D.D. & SCHIDLOVSKY G. (1985) Retention of ingested latex particles in Peyer's patches of germfree and conventional mice. Proc Soc Exp Biol Med 179, 522.
32. PAPPO J. & ERMAK T.H. (1989) Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin Exp Immunol 76, 144.
33. JANI P., HALBERT G.W., LANGRIDGE J. & FLORENCE A.T. (1989) The uptake and translocation of latex nanoparticles and microspheres after oral administration to rats. J Pharm Pharmacol 41, 809.
34. WHISTLER R.L., BEMILLER J.N. & PASCHALL E.F. (1984) Starch: Chemistry and Technology, 2nd edn. Academic Press, Inc., Orlando.
35. LACCOURREYE O., LAURENT A., POLIVKA M. et al. (1993) Biodegradable starch microspheres for cerebral arterial embolization. Invest. Radiol 28, 150-154.
36. The United States Pharmacopoeial Convention Inc. (1994) The United States Pharmacopoeia. Rand McNally, Taunton.
37. ELDRIDGE J.H., STAAS J.K., MEULBROEK J.A., TICE T.R. & GILLEY R.M. (1991) Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun 59, 2978.
38. O'HAGAN D.T., JEFFERY H., ROBERTS M.J.J., MCGHEE J.P. & DAVIS S.S. (1991) Controlled release microparticles for vaccine development. Vaccine 9, 768.
39. MCDERMOTT M.R., SMILEY J.R., BRAIS P.L J., RUDZROGA H.E. & BIENENSTOCK J. (1984) Immunity in the female genital tract after intravaginal vaccination with an attenuated strain of herpes simplex virus type 2. J Virol 51, 747.